A Review on Management of Varius Disease by Traditional Chinese Medicine Ganoderma lucidum

 

Poonam Rahangdale*, A. M. Wankhade, J. V. Vyas, V. V.  Paithnakar

Department of Pharmacology, Vidyabharti Collage of Pharmacy Amravati, Maharastra, 444602, India.

*Corresponding Author E-mail: poonamrahangdale1998@gamil.com

 

ABSTRACT:

Traditional Chinese medicine has used also known as "Lingzhi or Reishi," for more than 2000 years for its superior therapeutic activity, including its antitumor, antiallergenic, antiviral, hepatoprotective, antioxidant, immunomodulator, hypotensive, hypoglycaemic, anti-inflammatory, antithrombotic, antibacterial, and many other health benefits. G. lucidum has recently been under scientific study to see how many bioactive components it has that have an impact on human physiology. It has also been used to make powerful components for the pharmacology, nutraceuticals, and cosmetics sectors. For instance, mounting data suggests that this particular species of mushroom may be an effective antiviral drug for the treatment of a variety of viral infections, including enterovirus 71, dengue virus, and most recently coronavirus disease of 2019. (COVID-19). One of the oldest herbal remedies, Ganoderma lucidum grows in a wide range of places on deciduous trees (dead/dying trees). Adenosine, phenols, steroids, amino acids, lignin, vitamins, nucleotides, and nucleosides are among the 400 primary bioactive chemical components that it also includes. Polysaccharides, triterpenoids, polysaccharide-peptide complex, -glucans, lectins, and natural germanium (Ge) are all included. derived from Ganoderma fruiting bodies, mycelia, which also provide a wide range of useful medicinal qualities. However, we reviewed and described in this paper about pharmacological mechanisms for treating numerous disorders in relation to Ganoderma lucidum extract (polysaccharide and triterpenoid).

 

KEYWORDS: Fungus, Ganoderma lucidum, functional food, Traditional Chinese medicine, Therapeutic use.

 

 


INTRODUCTION:

Many different disorders have been treated with Ganoderma lucidum for thousands of years in Far Eastern traditional medicine1. In China, Japan, and other Asian nations, the oriental fungus Ganoderma lucidum has a long history of use in enhancing health and longevity. It has a huge, black, glossy, and woody outer mushroom. The word lucidus, which is Latin for "shiny" or "bright, " alludes to the mushroom's surface's varnished appearance2. Ganoderma lucidum is known as lingzhi in China whereas reishi or mannentake is the name of the Ganodermataceae family in Japan.

 

The Chinese word lingzhi, which means "herb of spiritual potency, " connotes both spiritual potency and the essence of immortality. It stands for success, happiness, divine power, and longevity. When it comes to grown mushrooms, Ganoderma lucidum is unique in that its pharmacological benefit is more important than its nutritional worth3.

 

 

Figure 1: Lingzhi mushroom (Ganoderma lucidum)4

 

Therapeutic mushrooms, which are fungi that include the fruit-body of fungus, are referred to as health foods, nutritional supplements, and nutraceuticals. Traditional Chinese Medicine has employed remedial fungal mushrooms for a very long time as herbal treatments in East Asian countries, but their use has only just started to rise modestly in the West5.

 

The basidiocarp and mycelium contain bioactive substances that are extremely useful in medicine6.

 

Growing mushrooms is said to have started in Asia in the 12th century in China. Presently, 70% of the world's mushroom production is carried out in China. Ganoderma lucidum, one of the first therapeutic mushrooms, is a wood-decaying fungus or phytopathogenic fungus that develops from white rot of a variety of trees and has a long history of use. For more than 2000 years, China and Japan have used the most popular medicinal mushrooms, Ganoderma lucidum, to treat a variety of illnesses and prevent others7.

 

Classification of Ganoderma lucidum Kingdom:

Fungi Phylum: Basidiomycota

Class: Agraicomycetes

Order: Polyporales

Family: Ganodermatacae

Genus: Ganoderma

Species: Ganoderma lucidum8.

 

Common name:

United States: Reishi mushroom, Ganoderma.

China: Ling zhi, ling zhi cao, ling chih, hong ling zhi8.

 

Macroscopic and Microscopic Description of Ganoderma lucidum:

Macroscopy:

Fruiting Body: Typically huge and shelf-like, although those from the tropics and the Old World tend to be smaller with a cap and stalk. There are also transitional forms, including a rare antlered type.

Cap: Fan- or kidney-shaped, circular to semicircular, 2–20 cm wide, and 4–8 cm thick.

Pores: 2–20 mm long tubes that produce spores are arranged in a single layer

Stalk: 3–14 cm long, 0.5–4 cm thick, sometimes twisted, and maybe expanded at the base

Antler form: This shape normally arises

 

Microscopy:

The mushroom displays three different types of hyphae, including generative, binding, and skeletal hyphae, along with sporadic basidia and basidiospores9.

 

Cultivation, Global use, and Habitat:

For growth and cultivation, different Ganoderma species require various circumstances10. Additionally, different varieties are preferred in various geographical locations. For instance, black Ganoderma lucidum is preferred in South China while red G. lucidum is preferred in Japan. The subtropical parts of the Orient are home to numerous wild variants of Ganoderma lucidum, which flourish in hot, humid climates. Ganoderma lucidum has been artificially cultivated utilising substrate like grain, sawdust, wood logs, and cork residues11.

 

Figure 2: Cultivation background of Ganoderma lucidum11.

 

Major bioactive components:

About 90% of the weight of most mushrooms is water. The remaining 10% is made up of some vitamins and minerals, 10-40% protein, 2-8% fat, 3-28-32% carbohydrate, 3-32% fibre, and 8-10% ash. The majority of the minerals include potassium, calcium, phosphorus, magnesium, selenium, iron, zinc, and copper12. The nonvolatile components of G. lucidum were examined, and it was discovered that the mushroom contains 1.8% ash, 26-28% carbohydrate, 3-5% crude fat, 59% crude fibre, and 7-8% crude protein. It also contains a wide range of bioactive molecules, including terpenoids, nitrogen compounds, enzyme steroids, phenols, nucleotides and their derivatives, glycoproteins, and polysaccharides. All of the necessary amino acids are present in mushroom proteins, which are particularly high in lysine and leucine. Numerous bioactive compounds, including terpenoids, steroids, phenols, nucleotides and their derivatives, glycoproteins, and polysaccharides are found in mushrooms13.


 

Figure 3: Chemical structure of lanosterol and three of the many triterpenes isolated from Ganoderma lucidum2

Table 1: The major bioactive compounds of Ganoderma lucidum and their biological effects14.

Bioactive compound

Biological effect

Triterpenoids

Antidiabetic, Antioxidant

Ganoderic acids T-Q and lucideinic acids A, D2, E2, and P

Anti-inflammatory

Ganoderic acids, ganodermin, ganoderic acid A, ganodermadiol, ganodermanondiol, lucidumol B, ganodermanontriol, ganoderic acid B, ganolucidic acid B

Antimicrobial

Triterpenoids, ganoderic acid, ganoderiol F, ganodermanontriol

Antiviral

Protein Ling Zhi-8 (LZ-8), lectin, ribosome-inactivating proteins, antimicrobial proteins, glycopeptides/glycoproteins, peptidoglycans/proteoglycans, ganodermin A, ribonucleases, proteinases, metalloproteases, laccases

Immunomodulator

Glycopeptides and peptidoglycan

Anticancer

Proteoglycans, proteins

Antidiabetic

Sterols; e.g., ergosterol

Provitamin D

Long-chain fatty acid

Antitumor

Polysaccharides (ganopoly)

Cardiovascular problems

olysaccharide–peptide complex

Antioxidans

Saponins

Anticancer and antioxidant

 

Figure 3: Postulated health benefits of lingzhi (Ganoderma lucidum)15

 


THERAPEUTIC USES:

Treatment of several diseases with Ganoderma lucidum has had notable pharmacological or physiological outcomes.

 

1.     Cancer:

In Ganoderma lucidum, the fruiting body, mycelia, or spores can all be used to extract a variety of chemical substances. There are various research from in vitro tests and animal and human in vivo investigations that demonstrate the chemo preventive and/or tumoricidal actions of many polysaccharides and triterpenes, the two major categories of components in the mushroom. Additionally, as reported by numerous studies, the antitumor activity of Ganoderma lucidum is accomplished by inducing programmed cell death. Furthermore, numerous human tumour cell lines have shown that the isolated compounds from Ganoderma lucidum act as autophagy modulators. In the same study, a methanolic extract of Ganoderma lucidum fruiting bodies (extraction at room temperature) inhibited the growth of a human gastric carcinoma cell line through a mechanism involving cellular autophagy16.

 

Figure 4: Anti-tumour activities of Ganoderma lucidum16.

 

2.     Immunomodulation:

In vitro or in vivo animal studies using a variety of Ganoderma lucidum components as immunomodulating agents have shown to improve immunological effector, induce cytokines, increase the growth of T or B lymphocytes, splenic mononuclear cells, NK cells, or dendritic cells17.

 

3.     Antioxidant and antiaging Activity:

By increasing the mobility of antioxidant enzymes, lowering radiation-induced oxidative DNA impairment, and reducing oxidative damage brought on by ROS, triterpenes or polysaccharide extract of Ganoderma lucidum displayed antioxidative effects in mouse splenocytes. Free radicals and reactive oxygen species (ROS) accelerate ageing and many age-related diseases. After UVB therapy, Ganoderma lucidum polysaccharides (GLPs) can reduce ROS production in fibroblasts18.

 

4.     Antidiabetic Activity:

It has been demonstrated that Ganoderma lucidum contains substances such polysaccharides, proteoglycans, proteins, and triterpenoids that have hypoglycemic effects. discovered that taking a Ganoderma lucidum spore powder (GLSP) caused a drop in blood sugar levels by encouraging glycogen synthesis and blocking gluconeogenesis19.

 

5.     Hepatoprotection and Gastric injury:

The GLPs and Ganoderma triterpenoids (GTs) have hepatoprotective actions and can successfully heal liver damage by acting on the immune system. By reducing lipid peroxidation, increasing antioxidant enzyme activity, and reducing apoptosis and immune-inflammatory response, GLPs can prevent hepatocyte injury20. Following acetic acid induction of gastric ulcers in rats, treatment with GL-PS fractions of 0.5 and 1.0 g/kg for 14 days markedly sped up the healing of the ulcers by 40% and 56%, respectively. In comparison to the control group, administration of 1.0 g/kg of the extract dramatically increased mucus and prostaglandin levels21.

 

6.     Viral and Bacterial Infections:

Finding substances that precisely prevent bacterial and viral growth without having an adverse effect on healthy cells is the main objective of research into the treatment of viral and bacterial diseases. The authors of this study came to the conclusion that oral Lingzhi hot water extract ingestion had a negligible impact on preventing influenza. The components of Ganomycin I (farnesyl hydroquinone) and Ganomycin B, which were isolated from Vietnamese G. colossum, showed substantial antiviral activity by inhibiting HIV 1 protease with IC50 values of 7.5 or 1.0 g/ml. However, a component of Ganomycin B competitively and equally inhibited the enzyme active site from docking with the crystal structure of HIV 1 protease.

 

a) Ganoderma lucidum against Enterovirus 71 (EV71):

By interfering with the viral particle and restricting the viral adsorption to the host cells, ganoderic acid Y (GLTB), a triterpenoid molecule of Ganoderma lucidum, may be able to inhibit EV71 infection21.

b) Ganoderma lucidum against Dengue Virus (DENV):

Triterpenoids, one of the bioactive substances derived from Ganoderma lucidum, have been suggested and investigated as antiviral medicines against many viral infections, such as the human immunodeficiency virus22.

 

c) Ganoderma lucidum against the 2019 Novel Coronavirus (SARS-CoV-2): Scutellarein and myricetin have been shown to effectively block nsP13, a SARS-CoV helicase protein, in vitro by changing its ATPase activity, suggesting that Ganoderma lucidum may represent a novel and potential source of bioactive natural chemicals with anticoronavirus activity23.

 

7.     Anti-inflammatory activity:

In animal models, a dose of 100 mg/kg B.W. of Ganoderma lucidum had anti-inflammatory effects comparable to those of 10 mg/kg B.W. of diclofenac, resulting in a 50% reduction in inflammation. However, treatment of Ganoderma lucidum triterpene concentrates fundamentally inhibits the release of inflammatory cytokines by macrophage cells, hence lowering the severity of inflammation24.

 

8.     Effect on cardiovascular function:

Ganoderma lucidum contained -tocopherol, which protected the mitochondria and decreased cardiac toxicity and mitochondrial dysfunction. the beneficial effects of ganopoly (a polysaccharide extract from Ganoderma lucidum) on people with coronary heart disease (CHD). The same authors demonstrated that a polysaccharide extract of G. lucidum led to lower serum cholesterol and blood pressure levels. normalise blood pressure or lower triglyceride levels. According to a clinical investigation, Ganoderma lucidum extract treatment was able to detect sustained blood pressure in individuals with early hypertension after two months. Additionally, studies showed that the Ganoderma lucidum extract (polysaccharide and peptide complexes) reduced blood cholesterol levels or stopped the progression of atherosclerosis in rats, and they also suggested a preventative effect on human endothelial cells in blood vessels.240 mg of six Ganoderma extract tablets were given daily for six months to the active group in a different clinical trial carried out in Japan with 53 hypertensive patients. The results revealed that Ganoderma lucidum extract-forming tablets had a significant effect on lowering blood pressure and hypertension while also showing no side effects related to Ganoderma treatment25.

 

9.     Antihyperlipidemic Activity:

Two distinct doses of Ganoderma lucidum were used in a research investigation, and the results showed that the glucans in Ganoderma lucidum have an impact on mice's cholesterol mechanisms. In mice given a high-cholesterol diet, the study showed that Ganoderma lucidum maintains total cholesterol level26.

 

10. Antiobesity Activity:

In a recent study to assess the impact of Ganoderma lucidum on obesity, it was discovered that the mycelium extract of the mushroom decreased inflammation, insulin resistance, and body weight in mice fed a high-fat diet27.

 


Fig. 5: Regulatory mechanism of GLPP on hyperlipidaemia, hypercholesterolemia, and gut microbiota dysbiosis in rats fed on HFD. GLPP: Ganoderma lucidum polysaccharide peptide; HFD: high fat diet; TG: triglyceride; TC: total cholesterol; LDL-C: low-density lipoprotein cholesterol; FFA: free fatty acids; SCFA: short-chain fatty acids; OSTα: organic solute transporter alpha; CYP7A1: cholesterol 7α-hydroxylase; SREBP-1C: sterol regulatory element-binding protein-1C; PPARα: peroxisome proliferator-activated receptor alpha; HMG-Coa: 3-hydroxy-3-methylglutaryl coenzyme A; BSEP: bile salt export pump; MRP3: multidrug-resistance-associated protein 3; OATP2: organic-anion-transporting polypeptides26.

 


11. Anxiolytic Activity:

In comparison to the usual anxiolytic medicine, the study's findings for the Ganoderma lucidum extract revealed a statistically significant increase in the amount of time spent in the light zone of the light/dark box28.

 

12. Antidepressant Activity:

The study's findings showed that Ganoderma lucidum has antidepressant-like activity in mice, similar to that of fluxetin. When compared to the vehicle control group, the study showed that Ganoderma lucidum significantly reduces the immobility in the FST and TST28.

 

13. Anti-Androgenic Activity:

The potential against androgens has been demonstrated by the study. The fruiting body of Ganoderma lucidum was used for the assessment of this activity. The androgen receptor can be inhibited by ganoderol A and ganoderol B, which can also suppress prostate growth. This study found that gonoderol B triggers androgen signalling, which may be useful in slowing the progression of prostate cancer and benign prostatic hyperplasia28.

 

14.  Activity against Topical Sarcoidosis:

The polysaccharide found in Ganoderma lucidum, which was studied in a study to determine the mushroom's effectiveness against topical sarcoidosis, has anti-inflammatory properties29.

15. Urinary Tract Protective Activity:

Males in Japan who had mild to moderate symptoms in the lower urinary tract were the subjects of two trials. The dosage of Ganoderma lucidum ethanol extract was 6 mg. It was discovered that the extract provided a reliable and secure treatment for the illness30.

 

16. Antianemic Activity:

When given to the rats for 84 days at a level of 300 mg/mg, Ganoderma lucidum prevented haemolysis in the rat erythrocytes that had been exposed to lead31.

 

17. Activity against Fibromyalgia in Women:

The alternative treatment Ganoderma lucidum was tested for the illness. The study included 64 fibromyalgia-afflicted female participants. The results showed that Ganoderma lucidum significantly improved aerobic endurance, lower body flexibility, and velocity when taken at a dose of 6 g per day for 42 days32.

 

CONCLUSION:

The chapter has finally come to a conclusion with research outlining the chemical constituents, cultivation, macro- and microscopy, and biological function with its chemical constituent. Due to the availability of many bioactive chemicals that have beneficial nutritional and therapeutic properties and are present in all regions of the fungus, Ganoderma lucidum is a prospective source of a variety of biological activities (fruit bodies, mycelium, and spores). As a result, Ganoderma lucidum has been utilised in traditional Chinese medicine to treat chronic disorders since ancient times. One of the well-known therapeutic mushrooms is Ganoderma lucidum. There have been numerous pharmacological research on Ganoderma lucidum that have demonstrated its efficacy and therapeutic potential. Numerous research have demonstrated the benefits of this medicinal mushroom, demonstrating that Ganoderma lucidum has few to no negative effects, confirming the mushroom's safety profile. This has demonstrated the potential of Ganoderma lucidum for the management and therapy of various bodily systems. The pharmacological action described above has demonstrated that this mushroom is capable of treating a wide range of illnesses and disorders, including diabetes, hepatitis, cancer, and others. All of Ganoderma lucidum's potential offered many researchers a topic of interest for evaluation and additional research, which will help in the evaluation of other pharmacological actions.

 

REFERENCE:

1.      Ćilerdžić J, Vukojević J, Stajić M, Stanojković T, Glamočlija J. Biological activity of Ganoderma lucidum basidiocarps cultivated on alternative and commercial substrate. Journal of ethnopharmacology. 2014; 155(1): 312-9.

2.      Wachtel-Galor S, Yuen J, Buswell JA, Benzie IF. Ganoderma lucidum (Lingzhi or Reishi). Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition. 2011.

3.      Amdekar S. Ganoderma lucidum (Reishi): source of pharmacologically active compounds. Curr Sci. 2016; 111(6): 976-8.

4.      Kumar A. Ganoderma Lucidum: A traditional chinese medicine used for curing tumors. Int. J. Pharm. Pharm. Sci. 2021; 13: 1-3.

5.      Singh C, Pathak P, Chaudhary N, Rathi A, Vyas D. Ganoderma lucidum: Cultivation and Production of Ganoderic and Lucidenic Acid. Recent Trends Mushroom Biol., Global books Organisation. 2021.

6.      Raman J, Lee SK, Im JH, Oh MJ, Oh YL, Jang KY. Current prospects of mushroom production and industrial growth in India. Journal of Mushroom. 2018; 16(4): 239-49.

7.      Rupeshkumar M, Chettri U, Paarakh PM. Ganoderma lucidum: A Review with Special Emphasis on the Treatment of Various Cancer. Journal of Applied Pharmacy. 2016; 8(4).

8.      Chang ST, Buswell JA. Ganoderma lucidum (Curt.: Fr.) P. karst. (Aphyllophoromycetideae)− a mushrooming medicinal mushroom. International Journal of Medicinal Mushrooms. 1999; 1(2).

9.      Singh C, Pathak P, Chaudhary N, Rathi A, Vyas D. Ganoderma lucidum: Cultivation and Production of Ganoderic and Lucidenic Acid. Recent Trends Mushroom Biol., Global books Organisation. 2021.

10.    Kapoor P, Sharma BM. Studies on different growth parameter of Ganoderma lucidum. IJSET 2014; 3: 1515-24

11.   Mayzumi F, Okamoto H, Mizuno T. IV. Cultivation of reishi (Ganoderma lucidum) Cultivation of reddish reishi (Ganoderma lucidum, Red). Food Reviews International. 1997; 13(3): 365-70.

12.   Khatian N, Aslam M. A review of Ganoderma lucidum (Reishi): A miraculous medicinal mushroom. Inventi Rapid: Ethnopharmacology. 2018; 4: 1-6.

13.   Mau JL, Lin HC, Chen CC. Non-volatile components of several medicinal mushrooms. Food Research International. 2001; 34(6): 521-6.

14.   Rupeshkumar M, Chettri U, Paarakh PM. Ganoderma lucidum: A Review with Special Emphasis on the Treatment of Various Cancer. Journal of Applied Pharmacy. 2016; 8(4).

15.   El Sheikha AF. Nutritional Profile and Health Benefits of Ganoderma lucidum “Lingzhi, Reishi, or Mannentake” as Functional Foods: Current Scenario and Future Perspectives. Foods. 2022; 11(7): 1030.

16.   Gill SK, Rieder MJ. Toxicity of a traditional Chinese medicine, Ganoderma lucidum, in children with cancer. Journal of Population Therapeutics and Clinical Pharmacology. 2008; 15(2).

17.   Gao Y, Chan E, Zhou S. Immunomodulating activities of Ganoderma, a mushroom with medicinal properties. Food Reviews International. 2004; 20(2): 123-61.

18.   Sharif S, Shahid M, Mushtaq M, Akram S, Rashid A. Wild mushrooms: A potential source of nutritional and antioxidant attributes with acceptable toxicity. Preventive nutrition and food science. 2017; 22(2): 124.

19.   Sirisidthi K, Kosai P, Jiraungkoorskul W. Antidiabetic activity of the lingzhi or reishi medicinal mushroom Ganoderma lucidum. SA Pharmaceutical Journal. 2016; 83(8): 45-7.

20.   Song CH, Yang BK, Ra KS, Shon DH, Park EJ, Go GI, Kim YH. Hepatoprotective effect of extracellular polymer produced by submerged culture of Ganoderma lucidum WK-003. Journal of microbiology and biotechnology. 1998; 8(3): 277-9.

21.   Gao Y, Tang W, Gao H, Chan E, Lan J, Zhou S. Ganoderma lucidum polysaccharide fractions accelerate healing of acetic acid-induced ulcers in rats. Journal of medicinal food. 2004; 7(4): 417-21.

22.   Bharadwaj S, Lee KE, Dwivedi VD, Yadava U, Panwar A, Lucas S, Pandey A, Kang SG. Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease. Scientific reports. 2019; 9(1): 1-2.

23.   Yang Y, Islam MS, Wang J, Li Y, Chen X. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective. International journal of biological sciences. 2020; 16(10): 1708.

24.   Ahmadi-Renani S, Fasihi-Ramandi M, Ahmadi K. Ganoderma lucidum: A promising anti-inflammatory medicinal plant. Journal of HerbMed Pharmacology. 2014; 3.

25.    Siwulski M, Sobieralski K, Golak-Siwulska I, Sokol S, Agnieszka S. Ganoderma lucidum (Curt.: Fr.) Karst.-health-promoting properties. Herba Polonica 2015; 61: 105-18

26.   Lv XC, Guo WL, Li L, Yu XD, Liu B. Polysaccharide peptides from Ganoderma lucidum ameliorate lipid metabolic disorders and gut microbiota dysbiosis in high-fat diet-fed rats. Journal of Functional Foods. 2019; 57: 48-58.

27.   Chang CJ, Lin CS, Lu CC, Martel J, Ko YF, Ojcius DM, Tseng SF, Wu TR, Chen YY, Young JD, Lai HC. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nature communications. 2015; 6(1): 1-9.

28.   Khatian N, Aslam M. A review of Ganoderma lucidum (Reishi): A miraculous medicinal mushroom. Inventi Rapid: Ethnopharmacology. 2018; 4: 1-6.

29.   Saylam Kurtipek G, Ataseven A, Kurtipek E, Kucukosmanoglu I, Toksoz MR. Resolution of cutaneous sarcoidosis following topical application of ganoderma lucidum (Reishi Mushroom). Dermatology and Therapy. 2016; 6(1): 105-9.

30.   Zhong D, Wang H, Liu M, Li X, Huang M, Zhou H, Lin S, Lin Z, Yang B. Ganoderma lucidum polysaccharide peptide prevents renal ischemia reperfusion injury via counteracting oxidative stress. Scientific reports. 2015; 5(1): 1-4.

31.   Hossain S, Bhowmick S, Islam S, Rozario L, Jahan S, Hassan M, Sarkar M, Choudhury BK, Ahmed S, Shahjalal H. Oral administration of ganoderma lucidum to lead-exposed rats protects erythrocytes against hemolysis: implicates to anti-anemia. Evidence-Based Complementary and Alternative Medicine. 2015 Jan 1; 2015.

32.   Mateo DC, Pazzi F, Muñoz FJ, Martínez JP, Olivares PR, Gusi N, Adsuar JC. Ganoderma lucidum improves physical fitness in women with fibromyalgia [Ganoderma lucidum mejora la condición física en mujeres con fibromyalgia].

 

 

 

 

Received on 19.01.2023         Modified on 02.02.2023

Accepted on 17.02.2023       ©A&V Publications All right reserved

Res. J. Pharmacognosy and Phytochem. 2023; 15(2):167-172.

DOI: 10.52711/0975-4385.2023.00026